J.P. Morgan Roundtable: The Regulatory Role In Accelerating Complex Therapies
Executive Summary
Companies working on cell and gene therapies and novel approaches to neurological diseases participated in a roundtable discussion during the J.P. Morgan Healthcare Conference about how regulators are supporting novel modalities, which in turn improves investor and partner sentiment.